Top Markets
#1 Siren Siren +45.54%
#2 Wrapped NXM Wrapped NXM +12.31%
#3 Cryptopia Cryptopia +9.12%
#4 Verus Coin Verus Coin +6.67%
#5 Mubarak Mubarak +6.18%
#6 Axelar Axelar +6.16%
#7 Notcoin Notcoin +5.51%
#8 OpenEden OpenEden +5.36%
#9 Stargate Finance Stargate Finance +4.89%
#10 Across Protocol Across Protocol +4.80%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Lutronic Corporation Lutronic Corporation

Lutronic Corporation

085370
Rangering i aksjer #11978
Lutronic Corporation, headquartered in Goyang, South Korea, is a global... Lutronic Corporation, headquartered in Goyang, South Korea, is a global innovator in the development and distribution of advanced laser and related technologies for both aesthetic and medical applications. The company's extensive portfolio encompasses a variety of sophisticated solutions, including: HOLLYWOOD SPECTRA, a distinguished laser platform with proprietary capabilities to diminish unwanted pigmentation and enhance skin luminosity. Accufit, designed to deliver direct muscle activation treatments for refined aesthetic outcomes. LUTRONIC GENIUS, which ensures exceptional precision with every energy pulse. CLARITY II, a cutting-edge dual-wavelength laser platform featuring intelligent breakthrough functionalities. LaseMD Ultra, providing tailored patient results with virtually no recovery period. SPECTRA XT, recognized as a state-of-the-art medical device. CLARITY, another dual-wavelength platform offering broad treatment versatility and increased operational speed. LASEMD, an adaptable platform capable of implementing a cosmeceutical delivery system for comprehensive skincare. SPECTRA, known for its effective treatments that require minimal patient downtime. PICOPLUS, specifically engineered for the treatment of melasma. ACTION II, which utilizes specialized multiple stacking fractional technology, allowing clinicians to control ablation depth and coagulation for a nearly painless procedure. Lutronic’s offerings further extend to include: eCO2, a premier fractional ablative CO2 laser. INFINI, a unique technology that delivers fractional radiofrequency energy through insulated microneedles. HEALITE II, which therapeutically harnesses incident light to modulate cellular function. SOLARI, an advanced IPL system. In addition to individual devices, the company provides integrated solutions such as: TotalSkin Solution, a comprehensive approach designed to address all layers of the skin and satisfy diverse patient expectations. KeraFactor Peptide Complex, a specialized treatment targeting hair and scalp health. The Hollywood Laser Peel, a swift and comfortable procedure facilitated by the Lutronic Spectra laser platform. Founded in 1997, the company was initially known as Max Engineering Ltd. before rebranding to Lutronic Corporation in 2006.
Aksjekurs
$25.38
Sist synkronisert: 2023-10-10
Markedsverdi
$634.81M
Endring (1 dag)
-7.17%
Endring (1 år)
0.00%
Land
KR
Handel Lutronic Corporation (085370)

Kategori

Healthcare
P/E-forhold for Lutronic Corporation (085370)
P/E-forhold per 2026 TTM: 0
Ifølge Lutronic Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet en P/E på 0.
P/E-forholdshistorikk for Lutronic Corporation fra 2026 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
Ikke nok data for de angitte datoene.
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.